TDOC Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

03
Preço $5.52
Capitalização de Mercado (MRQ) $1.00B
P/E (TTM) -5.6
EPS (TTM) $-0.99
Receita (TTM) $2.49B
ROE (TTM) -13.0%
Intervalo 52 Semanas $4–$10

TDOC Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

04
intervalo
barras

A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.

Sobre Teladoc Health, Inc. Common Stock Visão geral da empresa da Wikipedia

05 · wikidata

Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.

The company uses telephone and videoconferencing software and mobile apps to provide on-demand remote medical care. Teladoc Health is active in over 175 countries, and is traded on the New York Stock Exchange. It is the first and largest telemedicine company in the United States, and has acquired numerous other companies including BetterHelp in 2015, Best Doctors in 2017, and Catapult Health in 2025.

History

2002–2015

Teladoc was founded in 2002 in Dallas, Texas by G. Byron Brooks and Michael Gorton. It is the oldest and largest telemedicine company in the United States. Teladoc's initial business model allowed patients to remotely consult with state-licensed doctors at any time. Companies paid a monthly fee for their employees to access the service, while patients paid a flat fee for each consultation, originally about $35 to $40. With Gorton as both chairman and CEO, Teladoc launched nationally in 2005 at the Consumer Directed Health Care Conference in Chicago, Illinois. Teladoc had around 1 million members by the end of 2007, with large employers such as AT&T providing the service to employees as a health benefit. Jason Gorevic was named Teladoc's chief executive in 2009. In 2011, Aetna began offering Teladoc for its fully insured members in Florida and Texas, later offering Teladoc in all 50 states.

Teladoc acquired Consult A Doctor for $16.6 million cash in 2013, allowing smaller companies to access Teladoc's services. The Affordable Care Act led to a large number of insurance companies signing with Teladoc, resulting in a growth surge around 2014. By that time, insurance companies such as Blue Shield of California and Oscar had signed with Teladoc, as well as other companies such as Home Depot, T-Mobile, CalPERS, and Rent-A-Center. Teladoc acquired AmeriDoc for $17.2 million in May 2014. The acquisitions of Consult A Doctor and AmeriDoc, both Teladoc's main competitors, resulted in Teladoc becoming the largest telemedicine provider in the United States. After initial fundraising rounds in 2009, 2011, and 2013, Teladoc raised $50 million in 2014, bringing total funding to $100 million. Teladoc's sales doubled in both 2013 and 2014.

2015–2016

Teladoc Health became a public company on July 1, 2015 as the only telemedicine company on the New York Stock Exchange. Teladoc's initial public offering listed at $19 per share, giving the company a market capitalization of $758 million and an enterprise value of $620 million. The initial response to the IPO was positive, as shares surged 50% on the opening day. Three months after the IPO, health insurer Highmark, which represented 1.5% of Teladoc's 2015 revenue, ceased to renew a contract. Teladoc shares fell significantly as a result, before rising to earlier levels. That October, it was the first telehealth company to reach one million visits.

In 2015, Teladoc acquired the behavioral health services provider Compile Inc., operating as BetterHelp for $3.5 million, and competitor Stat Health Services (StatDoc) for $30 million. The following year Teladoc began aggressively expanding, acquiring other companies and launching health segments for dermatology, behavioral health, and sexual health. That year the company won a patent infringement lawsuit filed against competitor American Well.

In July 2016, Teladoc acquired HealthiestYou for $125 million ($45 million in cash and $80 million in stock). Teladoc had 15 million members by November 2016 and a market share of 75% in the United States. The largest national network of virtual care providers in the nation, its full-service suite was operational in 48 states, excluding Arkansas and Texas. In December 2016, the American Hospital Association exclusively endorsed Teladoc's telehealth technology platform. Teladoc logged 952,000 patient visits that year.

2017–2020

In its largest acquisition at the time, in 2017 Teladoc spent $440 million purchasing Best Doctors, a consultation firm and provider of medical second opinions and medical award listings. In 2019, ProPublica criticized companies such as Best Doctors for selling physician awards as pay-to-play. Teladoc had 7,500 clients in 2017, of which 220 were Fortune 1000 companies. Sales that year were $233 million, 89% higher than the year prior. Teladoc Health brands by 2018 included Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou.

On August 10, 2018, Teladoc, Inc. changed its name to Teladoc Health, Inc. while continuing to trade on the NYSE. Teladoc Health began partnering with CVS in August 2018 on remote consults at MinuteClinics. Teladoc Health acquired Advance Medical, a telemedicine company employing doctors in Latin America, Europe, and Asia, for $352 million in 2018. In December 2018, Teladoc Health's chief financial officer and chief operating officer Mark Hirschhorn resigned after a report that he engaged in a sexual relationship and insider trading with an employee. According to Yahoo Finance, stock value fell roughly 20% in the days following, while an investor class action lawsuit alleged that Teladoc Health had violated securities laws by failing to disclose Hirschhorn's behavior. Teladoc Health denied making false statements or any legal violations.

Active in 130 countries by 2019; that year, Teladoc acquired the French health company MédecinDirect and launched in Canada with the Teladoc Telemedicine Service. Joining from American Express, Mala Murthy was appointed CFO in June 2019.

In March 2020, Teladoc was providing "near real-time" surveillance data on the spread of coronavirus to the CDC. In July 2020, Teladoc acquired InTouch Health. In October 2020, Teladoc acquired the chronic care company Livongo Health for $13.9 billion in a deal described by the press as the third-largest for a U.S. company that year. The combined companies had an estimated enterprise value of $37 billion. Teladoc then brought in Florida Blue as the first insurer to use Livongo's digital diabetes program. Teladoc sued Amwell in October 2020 for alleged copyright infringement on nine patents, settling the case in July 2022.

2021–2024

In early 2021, paid membership in the U.S. was 52 million. In January 2021, Teladoc began offering a diabetes management service through Dexcom. Later that year, Teladoc Health launched myStrength Complete, a "unified mental health care platform for its B2B customers." In June 2021, Teladoc sued the company Avail for allegedly infringing on three patents related to telemedicine consoles.

On July 14, 2021, Teladoc announced it was collaborating with Microsoft to combine its delivery platform for hospitals and health systems with Microsoft Teams. Teladoc introduced its primary care service Primary360 on a national scale in October 2021. The program gave members access to both a primary physician and care team, with a system in place for followup reminders about appointments and personal maintenance. In February 2022, Teladoc Health launched Chronic Care Complete, a program to help patients manage multiple chronic conditions.

Teladoc had a valuation of roughly $11.3 billion by February 2022, and warned investors there might be a goodwill write-down that year related to the Livongo acquisition. Teladoc announced that Amazon could newly access Teladoc through Alexa and related devices, in February 2022, sparking debate among antitrust experts about the potential impact on the health industry. Amazon Care was shut down later that year.

In April 2022, Northwell Health began using the Teladoc platform with its clinicians, starting with 20 hospitals in the system. After Teladoc's stock value fluctuated significantly during the coronavirus pandemic, the company, in June 2022, was sued by investors alleging it had misrepresented its financial prospects, particularly in regard to its BetterHelp mental health subsidiary and chronic care business. Characterizing the lawsuit, which was later dismissed, as "frivolous," in July 2022, Teladoc reported revenue growth above analysts' projections, with significant growth in BetterHelp. In August 2022, Teladoc became the telehealth portal for Mayo Clinic Health System patients in Onalaska, Wisconsin.

In 2023, the company relocated its headquarters to new York City. Charles "Chuck" Divita, III, was appointed CEO in June 2024, leading the company's further expansion. In July, the firm launched Wellbound employee assistance program (EAP), incorporating BetterHelp into its U.S. employer-sponsored health plans.

2025–present

In January 2025, the company added its virtual cardiometabolic programs to Amazon Health Services health benefits connector. That year, Teladoc Health made a series of acquisitions, including Catapult Health in February, mental healthcare company UpLift in April, and Australia's Telecare virtual care firm in August.

In March 2025, the FTC fined BetterHelp $7.8 million for sharing consumer data with third-party social media sites, banning the company from health data disclosures for advertising purposes. Subsequent to the dismissed June 2022 lawsuit, a new class-action was filed by investors in the U.S. District Court for the Southern District of New York on May 17, 2025.

The company reported over 100 million U.S. members in July 2025, and launched new AI capabilities for healthcare workplaces to monitor and mitigate violence that October. In November, Teladoc Health joined with Lumeris, Deloitte, Nuna and Unite Us as Collaborative for Healthy Rural America, pledging to build a shared, integrated care platform, following individual states' plan approvals from the new Rural Health Transformation (RHT) Program of the U.S. Department of Health and Human Services.

Services and business model

Headquartered in New York City, the company operates two main components: Teladoc Health Integrated Care, its virtual care business for health plans, employers and health networks, and BetterHelp direct-to-consumer virtual mental health care. As a technology company, Teladoc Health is involved with artificial intelligence, analytics, telehealth devices, and "licensable platform services." The company uses telephone and videoconferencing software to provide on-demand remote medical care, with patients able to log on to the service at any time and be connected with a board-certified, state-licensed physician. Its app combines all of its services and programs.

Contracting largely with insurers and large employers, hospitals and health systems, Teladoc Health generates revenue through an annual, or monthly, fee charged per subscriber, as well as a fee for individual consults. Some companies waive or subsidize the consult fee for their employees.

By July 2020, the company stated it served "60 of the top 100 hospitals," with telemedical robots being used at hospitals such as Providence Regional Medical Center in Everett, Washington and Sheba Medical Center in Israel, minimizing the potential spread of coronavirus. Numerous studies analyzing Teladoc's impact on the industry have been conducted.

Disaster aid

Teladoc Health provides free telehealth visits to communities affected by federally declared natural disasters and public emergencies in the United States, including to victims of incidents such as the 2018 Camp Fire in Paradise, California, Hurricane Ida in 2021, and the 2025 Southern California wildfires. In March 2023, it began providing free care to residents in Mississippi affected by recent tornadoes and, in 2024, to communities in several states that were impacted by Hurricanes Milton and Helene.

Lobbying and legislation

Teladoc Health has been involved in lobbying for legislation in several states. In 2015 the Texas Medical Board ruled that state physicians had to physically meet patients before remotely treating ailments or prescribing medication. The bill undermined Teladoc Health's business model in Texas, where it had around two million subscribers. Teladoc Health sued in federal court over the rule in Teladoc v. Texas Medical Board, arguing the bill violated antitrust laws by inflating prices and limiting the supply of health care providers in the state. The bill, meant to go active on June 3, 2015, was stalled while the lawsuit went through a federal appeals court, allowing Teladoc Health to continue operating in Texas in the interim. Teladoc voluntarily dropped the lawsuit in 2017 after Texas passed a new bill allowing for remote treatment without a prior in-person interaction, which Teladoc Health had lobbied heavily for.

In January 2019, Teladoc Health opposed a telemedicine bill proposed by the North Dakota Board of Medicine, which required telemedicine providers to perform initial video examinations or have initial exams done by another physician. Proponents argued the bill protected patients, while Teladoc Health and critics argued it decreased access to healthcare in rural areas. The year prior, Teladoc Health had completed 1,500 virtual visits in the state. In May 2019, the company created a virtual care patient safety organization (PSO) dubbed the Institute for Patient Safety and Quality of Virtual Care.

In December 2021, Teladoc along with the American Medical Association, American Hospital Association, AARP, Amazon, Walmart, and CVS formed Telehealth Access for America, a coalition pushing for the extension of telehealth policies implemented by U.S. Congress in response to the COVID-19 pandemic. Subsequently, U.S. Senators Bill Cassidy and Tammy Baldwin introduced the Health Data Use and Privacy Commission Act in February 2022, which proposes creating a commission to study modernizing health data and privacy laws. The proposed legislation was supported by Teladoc and organizations such as the American College of Cardiology, IBM, and the United Spinal Association.

Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗

Wikidata ↗

setorHealth Care indústriaHealth Care funcionários4.648 paísUS

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

06
Receita$2.53B
2016-12-31 → 2025-12-31
EPS$-1.14
2019-12-31 → 2025-12-31
Fluxo de caixa livre$285M
2017-12-31 → 2025-12-31
Margem líquida-7.1%
2017-12-31 → 2025-12-31
Avaliação e Proporções 07–12

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Métrica Tendência de 5 anos TDOC média 5A Mediana de Pares Veredito
P/E (TTM) -5.6média 5A ≈-11.5 ≈-11.5 · ·
P/S (TTM) 0.4média 5A ≈2.3 ≈2.3 2.5 Subvalorizado
P/B (MRQ) 0.8média 5A ≈1.2 ≈1.2 2.9 Subvalorizado
Preço / FCF (TTM) 4.0média 5A ≈24.5 ≈24.5 · ·
Preço / Fluxo de Caixa (TTM) 3.8média 5A ≈23.2 ≈23.2 12.7 Subvalorizado
Preço / Valor Patrimonial Tangível (MRQ) 7.5 · · ·

A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.

valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

14
Surpresa Média 0.53%
Próximo relatório Out 27, 2026
PeríodoRelatórioEPS ActualEPS est.Surpresa
30 de Junho de 2026 Jul 27, 2026 $-0.21 $-0.25 17.6%
31 de Março de 2026 $-0.36 $-0.32 -12.6%
31 de Dezembro de 2025 $-0.14 $-0.19 26.9%
30 de Setembro de 2025 $-0.28 $-0.27 -3.2%
30 de Junho de 2025 $-0.19 $-0.27 28.7%
31 de Março de 2025 $-0.53 $-0.34 -54.2%

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

15
Demonstração de Resultados 18
Métrica Tendência 202520242023202220212020201920182017201620152014
Revenue $2.53B$2.57B$2.60B$2.41B$2.03B$1.09B$553M$418M$233M$123M$77M$44M
Cost of Revenue ···$744M$650M$391M$184M$129M$62M$32M$21M$10M
Gross Profit ·······$289M$172M$91M$56M$34M
R&D Expense $278M$307M$349M$334M$312M$165M$65M$54M$34M$22M$14M$8M
SG&A Expense $432M$435M$465M$450M$438M$507M$164M$117M$80M$49M$43M$18M
Operating Expenses $2.79B$3.59B$2.85B$16.06B$2.30B$1.60B$634M$489M$309M···
Operating Income $-263M$-1.02B$-249M$-13.65B$-266M$-506M$-80M$-71M$-75M$-63M$-56M$-15M
Interest Expense ·$24M$22M$22M$81M·······
Interest Income $37M$57M$47M$13M$776.0K·······
Other Non-op $10M$-6M$4M$-859.0K$5M$-545.0K$342.0K·····
Pretax Income $-236M$-994M$-220M$-13.66B$-385M$-576M$-109M$-97M$-107M$-74M$-58M$-17M
Income Tax $-35M$8M$760.0K$-4M$44M$-91M$-11M$118.0K$-225.0K$510.0K$36.0K$388.0K
Net Income $-200M$-1.00B$-220M$-13.66B$-429M$-485M$-99M$-97M$-107M$-74M$-58M$-17M
EPS (Basic) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
EPS (Diluted) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
Shares (Basic) 176,221,530170,564,088164,578,219161,457,123156,939,34990,509,22971,844,535·····
Shares (Diluted) 176,221,530170,564,088164,578,219161,457,123156,939,34990,509,22971,844,535·····
EBITDA $-263M$-1.02B$-249M$-13.40B$-61M$-437M$-80M$-35M$-56M·$-51M·
Balanço Patrimonial 28
Métrica Tendência 202520242023202220212020201920182017201620152014
Cash & Equivalents $781M$1.30B$1.12B$918M$893M$733M$514M$424M$43M$50M$55M$46M
Short-term Investments ·······$55M$79M$16M$82M·
Receivables $193M$214M$217M$211M$169M$169M$57M$44M$27M$14M$12M$7M
Inventory $38M$38M$30M$56M$73M$56M$0·····
Prepaid Expense $107M$113M$118M$130M$87M$47M$14M$11M$7M$3M$2M$966.0K
Other Current Assets $2M$3M$7M$12M$6M·······
Current Assets $1.12B$1.66B$1.49B$1.32B$1.23B$1.06B$588M$533M$156M$83M$152M$54M
PP&E (Net) $27M$29M$32M$30M$27M$29M$10M$10M$9M$7M$6M$1M
PP&E (Gross) $112M$101M$92M$77M$61M$51M$26M$22M$17M$12M$8M$2M
Accum. Depreciation $85M$71M$60M$48M$34M$22M$16M$12M$8M$4M$2M$1M
Goodwill $283M$283M$1.07B$1.07B$14.50B$14.58B$746M$737M$499M$188M$56M$28M
Intangibles $1.30B$1.43B$1.68B$1.84B$1.91B$2.02B$225M$247M$160M$25M$15M$8M
Other Non-current Assets $106M$81M$80M$49M$21M$18M$7M$1M$858.0K$415.0K$293.0K$296.0K
Total Assets $2.86B$3.52B$4.39B$4.35B$17.73B$17.76B$1.60B$1.53B$824M$304M$230M$92M
Accounts Payable $48M$33M$44M$48M$47M$46M$9M$8M$4M$2M$2M$2M
Current Liabilities $405M$942M$421M$400M$331M$333M$90M$62M$40M$21M$18M$10M
Capital Leases $34M$32M$43M$38M$42M$43M$25M$0····
Deferred Tax $29M$50M$49M$51M$76M$102M$22M$32M$13M$2M$1M$482.0K
Other Non-current Liabilities $643.0K$720.0K$1M$2M$1M$2M$9M$6M$5M$8M$7M$3M
Total Liabilities $1.47B$2.03B$2.07B·········
Long-term Debt ·········$44M$26M$26M
Total Debt ····$0$43M····$26M·
Common Stock $178.0K$173.0K$167.0K$163.0K$160.0K$150.0K$73.0K$70.0K$61.0K$46.0K$38.0K$2.0K
Retained Earnings $-16.43B$-16.23B$-15.23B$-15.01B$-1.42B$-993M$-508M$-409M$-312M$-205M$-131M$-72M
AOCI $-35M$-38M$-37M$-43M$-6M$19M$-17M$-13M$4M$-1.0K$-42.0K·
Stockholders' Equity $1.39B$1.49B$2.33B$2.31B$16.05B$15.88B$1.01B$1.01B$559M$231M$179M$-68M
Liabilities + Equity $2.86B$3.52B$4.39B$4.35B$17.73B$17.76B$1.60B$1.53B$824M$304M$230M$92M
Shares Outstanding 178,315,400173,405,016166,658,253162,840,360160,469,325150,281,09972,761,94170,516,24961,534,10146,201,56338,524,9222,037,999
Fluxo de Caixa 18
Métrica Tendência 202520242023202220212020201920182017201620152014
D&A ···$256M$204M$69M$39M$36M$19M$8M$5M$2M
Stock-based Comp $80M$146M$202M$218M$303M$476M$67M$44M$31M$8M$3M$533.0K
Deferred Tax $-41M$-1M$-2M$-8M$41M$-91M$-11M$-2M$-591.0K$510.0K$36.0K$388.0K
Amort. of Intangibles $351M$363M$326M$245M$195M$65M$36M$32M$15M$6M$4M$2M
Restructuring $19M$20M$17M$7M···$1M····
Other Non-cash ···$13.38B$75M$-23M·$15M$23M·$3M·
Operating Cash Flow $294M$294M$350M$189M$194M$-54M$30M$-5M$-34M$-52M$-47M$-11M
CapEx $9M$11M$11M$16M$9M$4M$4M$4M$3M$2M$6M$1M
Investing Cash Flow $-266M$-124M$-156M$-168M$-73M$-591M$25M$-257M$-448M$26M$-108M·
Debt Issued ·······$10.0K$167M$35M$7M$20M
Net Debt Issued ······$0$10.0K$-60M·$468.0K·
Stock Issued ·····$0$0$331M$259M$250.0K$163M·
Stock Repurchased ···········$368.0K
Net Stock Activity ·····$0$0$331M$259M···
Financing Cash Flow $-552M$8M$11M$6M$41M$859M$35M$646M$475M$21M$164M·
Taxes Paid $9M$9M$7M$3M$4M$1M$1M$441.0K$137.0K···
Free Cash Flow $285M$283M$339M$173M$185M$-58M$26M$-9M$-37M·$-53M·
Levered FCF ·$259M$316M·········
Lucratividade 8
Métrica Tendência 202520242023202220212020201920182017201620152014
Gross Margin ·······69.2%73.6%·72.8%·
Operating Margin -10.4%-39.7%-9.6%-567.3%-13.1%-46.3%-14.5%-17.0%-32.3%·-72.1%·
Net Margin -7.9%-39.0%-8.5%-567.5%-21.1%-44.4%-17.9%-23.2%-45.8%·-75.0%·
Pretax Margin -9.3%-38.7%-8.4%-567.7%-18.9%-52.6%-19.8%-23.2%-45.9%·-74.9%·
EBITDA Margin -10.4%-39.7%-9.6%-556.6%-3.0%-39.9%-14.5%-8.4%-24.1%·-65.8%·
ROA -6.3%-25.3%-5.0%-123.7%-2.4%-5.0%-6.3%-8.2%-18.9%·-36.1%·
ROE -14.3%-66.8%-9.5%-326.8%-2.7%-5.4%-9.8%-9.5%-27.0%·-104.5%·
ROIC -16.1%-69.0%-10.7%-591.5%-1.8%-2.7%-7.2%-7.0%-13.5%·-27.2%·
Liquidez e Solvência 5
Métrica Tendência 202520242023202220212020201920182017201620152014
Current Ratio 2.81.83.53.33.73.26.58.53.9·8.4·
Quick Ratio 2.41.63.22.83.22.76.38.43.7·8.3·
Debt / Equity ····0.00.0····0.1·
LT Debt / Equity ··········0.1·
Interest Coverage ·-42.9-11.2·········
Eficiência 3
Métrica Tendência 202520242023202220212020201920182017201620152014
Asset Turnover 0.80.60.60.20.10.10.40.40.4·0.5·
Inventory Turnover ···11.510.013.8······
Receivables Turnover 12.411.912.212.712.09.711.011.811.4·8.2·
Por Ação 5
Métrica Tendência 202520242023202220212020201920182017201620152014
Book Value / Share $7.77$8.60$13.96$14.17$99.99$105.69$13.94$14.37$9.08·$4.63·
Revenue / Share $14.36$15.07$15.81$14.91$12.95·······
Cash Flow / Share $1.67$1.72$2.13$1.17$1.24·······
Cash / Share $4.38$7.49$6.74$5.64$5.57$4.88$7.07$6.01$0.70·$1.43·
EPS (TTM) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
Taxas de Crescimento 3
Métrica Tendência 202520242023202220212020201920182017201620152014
Revenue YoY -1.5%-1.3%8.1%18.4%85.8%·······
Revenue CAGR 3Y 1.7%8.1%33.5%·········
Revenue CAGR 5Y 18.3%···········
Avaliação (TTM) 13
Métrica Tendência 202520242023202220212020201920182017201620152014
Revenue TTM $2.53B$2.57B$2.60B$2.41B$2.03B$1.09B$553M$418M$233M$123M$77M·
Net Income TTM $-200M$-1.00B$-220M$-13.66B$-429M$-485M$-99M$-97M$-107M$-74M$-58M·
Market Cap $1.25B$1.58B$3.59B$3.85B$14.73B$30.05B$6.09B$3.50B$2.14B·$692M·
Enterprise Value ····$13.84B$29.36B····$581M·
P/E -6.1-1.5-16.1-0.3-33.6-37.3-60.7·····
P/S 0.50.61.41.67.227.511.08.49.2·8.9·
P/B 0.91.11.51.70.91.96.03.53.8·3.9·
P / Cash Flow 4.25.410.320.376.0-561.6203.9-719.2-62.3·-14.7·
P / FCF 4.45.610.622.379.4-522.3231.1-394.0-57.8·-12.9·
EV / EBITDA ····-225.4-67.2····-11.4·
EV / FCF ····74.6-510.3····-10.9·
EV / Revenue ····6.826.8····7.5·
Earnings Yield -16.3%-64.6%-6.2%-357.7%-3.0%-2.7%-1.7%·····

Período mais recente à esquerda · valores nulos mostrados como ·

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

16
Métrica 2025-12-312024-12-312023-12-312022-12-312021-12-31
Receita $2.53B $2.57B $2.60B $2.41B $2.03B
Margem Operacional % -10.4% -39.7% -9.6% -567.3% -13.1%
Lucro líquido $-200M $-1.00B $-220M $-13.66B $-429M
EPS Diluído $-1.14 $-5.87 $-1.34 $-84.60 $-2.73

Investidores institucionais (13F) 392 declarantes · $1.5B total · Em 30 de Setembro de 2026

17

Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.

Detentores 392
Valor detido $1.5B
Novas posições 65
Posições encerradas 34
Atividade institucional — Q2 2026 vs trimestre anterior
Novas posições Posições encerradas Aumentou Diminuído Variação líquida de ações
65 (-2 vs trimestre anterior) 34 (-38 vs trimestre anterior) 111 (-8 vs trimestre anterior) 94 (+9 vs trimestre anterior) +11.8M

Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.

Instituição Valor Ações % de 13F rastreado Tipo
VANGUARD GROUP INC $150.385.949 21.483.707 9,91% Ações
BlackRock, Inc. $137.572.176 16.223.134 9,07% Ações
VANGUARD PORTFOLIO MANAGEMENT LLC $107.573.820 12.685.592 7,09% Ações
Point72 Asset Management, L.P. $69.874.581 8.239.927 4,61% Ações
RENAISSANCE TECHNOLOGIES LLC $68.457.700 8.072.842 4,51% Ações
Voss Capital, LP $68.235.838 8.046.679 4,50% Ações
VANGUARD CAPITAL MANAGEMENT LLC $67.458.671 7.955.032 4,45% Ações
DIMENSIONAL FUND ADVISORS LP $62.515.646 7.371.699 4,12% Ações
STATE STREET CORP $42.080.999 4.962.382 2,77% Ações
AMERICAN CENTURY COMPANIES INC $41.505.394 4.894.504 2,74% Ações
Allianz Asset Management GmbH $39.572.734 4.666.596 2,61% Ações
GEODE CAPITAL MANAGEMENT, LLC $39.472.353 4.653.834 2,60% Ações
GOLDMAN SACHS GROUP INC $32.412.969 3.822.284 2,14% Ações
Monaco Asset Management SAM $26.864.462 3.167.979 1,77% Ações
JUPITER ASSET MANAGEMENT LTD $26.370.375 3.109.714 1,74% Ações
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $25.976.377 3.063.252 1,71% Ações
Quantinno Capital Management LP $23.904.416 2.818.917 1,58% Ações
FEDERATED HERMES, INC. $18.037.027 2.127.008 1,19% Ações
UBS Group AG $17.401.181 2.052.026 1,15% Ações
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $17.299.632 2.040.051 1,14% Ações
AMERIPRISE FINANCIAL INC $16.998.584 2.004.550 1,12% Ações
Pale Fire Capital SE $16.737.502 1.973.762 1,10% Ações
SUSQUEHANNA INTERNATIONAL GROUP, LLP $16.435.088 1.938.100 1,08% Opção de compra
NORTHERN TRUST CORP $15.055.374 1.775.398 0,99% Ações
AQR CAPITAL MANAGEMENT LLC $14.855.924 1.751.878 0,98% Ações
SUSQUEHANNA INTERNATIONAL GROUP, LLP $11.710.032 1.380.900 0,77% Opção de venda
BRIDGEWAY CAPITAL MANAGEMENT, LLC $11.348.708 1.338.291 0,75% Ações
SUSQUEHANNA INTERNATIONAL GROUP, LLP $11.229.479 1.324.231 0,74% Ações
MORGAN STANLEY $11.055.129 1.303.670 0,73% Ações
VANGUARD FIDUCIARY TRUST CO $10.120.074 1.193.405 0,67% Ações
BNP PARIBAS FINANCIAL MARKETS $9.796.800 1.155.283 0,65% Ações
FRANKLIN RESOURCES INC $9.710.439 1.145.099 0,64% Ações
Allspring Global Investments Holdings, LLC $9.024.853 991.742 0,59% Ações
Freestone Grove Partners LP $7.338.160 865.349 0,48% Ações
Man Group plc $6.880.545 811.385 0,45% Ações
PRINCIPAL FINANCIAL GROUP INC $6.827.859 805.172 0,45% Ações
CITADEL ADVISORS LLC $6.795.024 801.300 0,45% Opção de venda
Union Square Park Capital Management, LLC $6.784.000 800.000 0,45% Ações
CITADEL ADVISORS LLC $6.532.093 770.294 0,43% Ações
FMR LLC $6.449.076 760.504 0,43% Ações
TCW GROUP INC $6.248.039 736.797 0,41% Ações
Voss Capital, LP $5.936.000 700.000 0,39% Opção de compra
Empowered Funds, LLC $5.764.619 679.790 0,38% Ações
Bank of New York Mellon Corp $5.535.043 652.717 0,36% Ações
D. E. Shaw & Co., Inc. $5.420.493 639.209 0,36% Ações
PEAK6 LLC $5.227.920 616.500 0,34% Opção de compra
CITADEL ADVISORS LLC $5.114.288 603.100 0,34% Opção de compra
Squarepoint Ops LLC $5.089.696 600.200 0,34% Opção de compra
JANE STREET GROUP, LLC $5.088.848 600.100 0,34% Opção de venda
JPMORGAN CHASE & CO $4.283.818 484.856 0,28% Ações

Mostrar todos os 392 proprietários institucionais →

Ativistas e proprietários de 5%+ 2 participações

18

Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.

Declarante Declarado Participação Status Propósito Declaração
Kinnevik AB (publ), Invik S.A. ×3 declarações 15 de Abril de 2021 · Declaração inicial · SEC
General Catalyst Group Management Holdings GP, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management, LLC, General Catalyst Group VI, L.P., General Catalyst Partners VI, L.P., General Catalyst GP VI, LLC, General Catalyst Group VIII, L.P., General Catalyst Group VIII Supplemental, L.P., General Catalyst Partners VIII, L.P., General Catalyst GP VIII, LLC, GC Partners Holdings, LP, GCSE VIII, L.P., GCSE VIII, LLC, GCGM Investment Holdings, LP, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow, Hemant Taneja ×3 declarações 16 de Março de 2021 · Declaração inicial · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Executivos da empresa 56 insiders · 29 diretores · 24 conselheiros

19
Investidor com informação privilegiada Função Última atividade Ações detidas Compras 12m Vendas 12m Líquido 12m
Charles Divita III CHIEF EXECUTIVE OFFICER 10 de Setembro de 2026 M 465.535 0 7 $-1.035.229
Laizer Kornwasser Advisor to the CEO 1 de Agosto de 2024 M 99.929 0 0 $0
Jason N Gorevic CHIEF EXECUTIVE OFFICER 19 de Março de 2024 A 653.073 0 0 $0
Michael F Grasher Chief Financial Officer 1 de Setembro de 2026 A · 0 0 $0
Mala Murthy CHIEF FINANCIAL OFFICER 29 de Agosto de 2025 M 142.385 0 0 $0
Mark Hirschhorn Executive VP, COO and CFO 13 de Dezembro de 2018 M 10.000 0 0 $0
Carlos Nueno President, International 1 de Setembro de 2026 M 64.744 0 4 $-218.769
Fernando M. Rodrigues President of BetterHelp 1 de Setembro de 2026 M 0 0 8 $-469.637
Kelly Bliss President, U.S. Group Health 1 de Setembro de 2026 M 92.832 0 7 $-343.192
Peter A Mcclennen President 15 de Julho de 2019 M 0 0 0 $0
Michael Willem Waters CHIEF OPERATING OFFICER 30 de Agosto de 2024 M 78.309 0 0 $0
David William Sides Chief Operating Officer 29 de Julho de 2021 M 11.031 0 0 $0
Joseph Ronald Catapano Chief Accounting Officer 1 de Setembro de 2026 M 12.865 0 7 $-48.940
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY 1 de Setembro de 2026 M 117.616 0 4 $-289.541
Vidya Raman-Tangella CHIEF MEDICAL OFFICER 4 de Setembro de 2024 S 33.665 0 0 $0
Andrew Turitz EVP, CORPORATE DEVELOPMENT 4 de Setembro de 2024 S 20.773 0 0 $0
James L. Cave INTERIM CAO 30 de Agosto de 2024 M 13.808 0 0 $0
Nikolaos P. Nanis Chief Technology Officer 30 de Agosto de 2024 M 75.410 0 0 $0
Arnnon Geshuri CHIEF PEOPLE OFFICER 30 de Agosto de 2024 M 44.914 0 0 $0
Daniel Trencher CHIEF STRATEGY OFFICER 30 de Agosto de 2024 M 31.465 0 0 $0
Stephany Verstraete CHIEF MARKETING OFFICER 30 de Agosto de 2024 M 48.843 0 0 $0
Richard J Napolitano CHIEF ACCOUNTING OFFICER 19 de Março de 2024 A 18.077 0 0 $0
Claus Torp Jensen CHIEF INNOVATION OFFICER 1 de Dezembro de 2023 M 20.703 0 0 $0
Lewis Levy Chief Medical Officer 1 de Outubro de 2020 M 8.766 0 0 $0
Michelle Bucaria Chief Human Resources Officer 1 de Setembro de 2020 M 3.232 0 0 $0
Christopher Caridi Chief Accounting Officer 1 de Julho de 2020 A · 0 0 $0
Gabriel R. Cappucci Senior VP, Controller and CAO 16 de Abril de 2020 M 988 0 0 $0
Michael H. King Chief Sales Officer 25 de Maio de 2017 A 61.459 0 0 $0
Peter N. Nieves EVP and CRO 13 de Março de 2017 A · 0 0 $0
Mark V Anquillare Conselheiro 3 de Agosto de 2026 A · 0 0 $0
Catherine Jacobson Conselheiro 21 de Maio de 2026 A 66.853 0 0 $0
Mark Douglas Smith Conselheiro 21 de Maio de 2026 A 8.355 0 0 $0
Kenneth H Paulus Conselheiro 21 de Maio de 2026 A 10.000 1 0 $69.400
David B Snow JR Conselheiro 21 de Maio de 2026 A 113.032 0 0 $0
David L Shedlarz Conselheiro 21 de Maio de 2026 A 61.266 0 0 $0
Susan R Salka Conselheiro 30 de Março de 2026 A · 0 0 $0
Michael S Smith Conselheiro 18 de Fevereiro de 2026 A · 0 0 $0
Jason Eric Evans Conselheiro 19 de Dezembro de 2025 M 9.145 0 0 $0
Thomas Mckinley Conselheiro 22 de Maio de 2025 A 56.544 0 0 $0
Karen L Daniel Conselheiro 22 de Maio de 2024 M 36.995 0 0 $0
William H. Frist Conselheiro 26 de Maio de 2022 A 12.918 0 0 $0
Christopher Bischoff Conselheiro 17 de Maio de 2022 M 7.195 0 0 $0
Hemant Taneja Conselheiro 19 de Abril de 2021 S 118.760 0 0 $0
Glen Tullman Conselheiro 1 de Abril de 2021 M 275.793 0 0 $0
Helen Darling Conselheiro 11 de Junho de 2020 M 918 0 0 $0
Arneek Multani Conselheiro 30 de Maio de 2019 A 918 0 0 $0
Brian P Mcandrews Conselheiro 30 de Maio de 2019 A 1.965 0 0 $0
Tom Mawhinney Conselheiro 25 de Maio de 2018 M 46.203 0 0 $0
Martin R Felsenthal Conselheiro 8 de Agosto de 2016 A 10.860 0 0 $0
Dana G Mead Jr. Conselheiro 8 de Agosto de 2016 A 202 0 0 $0
James K Outland Conselheiro 13 de Julho de 2015 M 49.986 0 0 $0
CHP III Management, L.L.C. Detentor de 10% 26 de Abril de 2017 J 2.480.468 0 0 $0
CHP III LP Detentor de 10% 26 de Abril de 2017 J 2.480.468 0 0 $0
Sandra L Fenwick · 21 de Maio de 2026 A 12.070 0 0 $0
Yulun Wang · 25 de Janeiro de 2021 S 219.507 0 0 $0
Michael Goldstein · 11 de Junho de 2020 M 0 0 0 $0

Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto

Participação em ETFs Detido por 37 ETFs

20

O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.

Fundo Peso Unidades Em Fonte
IHF · iShares Trust 0,16% 347.966 SH 11 de Setembro de 2026 Diário
VTWV · VANGUARD SCOTTSDALE FUNDS 0,10% 159.976 SH 19 de Agosto de 2026 Diário
DFSV · Dimensional ETF Trust 0,08% 1.038.485 NS 31 de Julho de 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,05% 1.047.849 SH 19 de Agosto de 2026 Diário
ESML · iShares Trust 0,05% 219.811 SH 11 de Setembro de 2026 Diário
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,05% 47.383 NS 31 de Julho de 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,04% 29.737 SH 19 de Agosto de 2026 Diário
RSSL · Global X Funds 0,04% 87.202 NS 31 de Julho de 2026 N-PORT
IWM · iShares Trust 0,04% 4.676.471 SH 11 de Setembro de 2026 Diário
VBR · VANGUARD INDEX FUNDS 0,03% 2.631.374 SH 19 de Agosto de 2026 Diário
PNQI · Invesco Exchange-Traded Fund Trust 0,03% 27.091 SH 1 de Outubro de 2026 Diário
DFAT · Dimensional ETF Trust 0,02% 528.876 NS 31 de Julho de 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,02% 2.084.219 SH 19 de Agosto de 2026 Diário
VB · VANGUARD INDEX FUNDS 0,02% 4.153.113 SH 19 de Agosto de 2026 Diário
VHT · VANGUARD WORLD FUND 0,02% 535.056 SH 19 de Agosto de 2026 Diário
FHLC · FIDELITY COVINGTON TRUST 0,02% 83.458 NS 31 de Julho de 2026 N-PORT
DFAS · Dimensional ETF Trust 0,01% 325.784 NS 31 de Julho de 2026 N-PORT
DXUV · Dimensional ETF Trust 0,01% 11.242 NS 31 de Julho de 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0,01% 176.576 SH 1 de Outubro de 2026 Diário
WSML · iShares Trust 0,01% 10.496 SH 11 de Setembro de 2026 Diário
TILT · FlexShares Trust 0,01% 21.330 NS 31 de Julho de 2026 N-PORT
DFAC · Dimensional ETF Trust 0,01% 449.072 NS 31 de Julho de 2026 N-PORT
DFSU · Dimensional ETF Trust 0,01% 18.459 NS 31 de Julho de 2026 N-PORT
DCOR · Dimensional ETF Trust 0,00% 23.195 NS 31 de Julho de 2026 N-PORT
DSI · iShares Trust 0,00% 25.114 SH 10 de Setembro de 2026 Diário
DFUS · Dimensional ETF Trust 0,00% 82.328 NS 31 de Julho de 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 43.186 NS 31 de Julho de 2026 N-PORT
ITOT · iShares Trust 0,00% 232.868 SH 11 de Setembro de 2026 Diário
IWV · iShares Trust 0,00% 45.761 SH 3 de Setembro de 2026 Diário
DFUV · Dimensional ETF Trust 0,00% 16.298 NS 31 de Julho de 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0,00% 5.687.282 SH 19 de Agosto de 2026 Diário
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 15.175 SH 19 de Agosto de 2026 Diário
IWN · iShares Trust · 1.697.159 SH 11 de Setembro de 2026 Diário
SVAL · iShares Trust · 100.159 SH 3 de Setembro de 2026 Diário
ISCB · iShares Trust · 7.717 SH 11 de Setembro de 2026 Diário
ISCV · iShares Trust · 38.629 SH 11 de Setembro de 2026 Diário
SMLF · iShares Trust · 597.716 SH 11 de Setembro de 2026 Diário

TDOC Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

21
classificação · 31 analistas MANTER
Alvo mediano $7.50 +35,9%
4 12,9% Compra forte
7 22,6% Compra
20 64,5% Manter
0 0,0% Venda
0 0,0% Venda forte

Preço-alvo de 12 meses

17 analistas · 2026-10-02

Alvo médio $7.68 +39,1%

Agora Preço atual $5.52
Mín$5.50 Média$7.68 Máx$10.50

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

22

Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.

Ticker Capitalização de Mercado P/E Receita YoY Margem Líquida ROE Margem Bruta
TDOC $1.25B -6.1 -1.5% -7.9% -14.3% ·
HTFL $2.49B -9.2 39.9% -66.3% 39.3% 76.8%
SDGR · -12.7 23.3% -40.4% -29.2% 55.7%
CERT $1.40B -881.0 8.8% -0.38% -0.15% ·
GDRX · 30.1 0.57% 3.8% 4.8% ·
HSTM $682M 37.8 4.3% 6.0% 5.2% ·
PHR · 335.8 14.5% 0.48% 0.73% ·
CTEV $708M -2.5 3.7% -29.4% 265.9% ·
VEEV $33.40B 37.5 16.3% 28.4% 13.1% 75.5%

Últimas notícias Notícias recentes mencionando esta empresa

23

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

26

Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.

Sua seleção é salva e acompanha você em todos os tickers.

Fonte: SEC 10-Q arquivado Jul 30, 2026